Trademark Overview
On Tuesday, February 20, 2024, a trademark application was filed for GENETIQ with the United States Patent and Trademark Office. The USPTO has given the GENETIQ trademark a serial number of 98413156. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 2, 2025. This trademark is owned by PREPAIRE IRELAND IP HOLDING LIMITED. The GENETIQ trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Supplements used in genetic therapy and immunotherapy therapy; Nutraceuticals used as supplements; herbal preparations used as supplements; pharmaceuticals used as supplements in genetic therapy and immunotherapy therapy
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy; Product development in the field of identifying immunotherapy therapy; research and development of technology in the field of immunotherapy therapy; scientific research for medical purposes in the field of immunotherapy therapy; laboratories, clinics, hospitals providing immunotherapy therapy and genetic therapy; laboratories, clinics, and hospitals using substances made by the body or in a laboratory to boost the immune system and help the body find and destroy cancer cells
